1. Home
  2. PLPC vs PHAR Comparison

PLPC vs PHAR Comparison

Compare PLPC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$228.89

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.81

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLPC
PHAR
Founded
1947
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PLPC
PHAR
Price
$228.89
$16.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.00
AVG Volume (30 Days)
88.2K
27.8K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
0.37%
N/A
EPS Growth
13.62
N/A
EPS
7.55
0.00
Revenue
$663,346,000.00
$362,274,000.00
Revenue This Year
$16.31
$25.19
Revenue Next Year
$13.74
$4.47
P/E Ratio
$29.85
$2,998.75
Revenue Growth
15.93
26.78
52 Week Low
$118.99
$7.50
52 Week High
$245.99
$18.30

Technical Indicators

Market Signals
Indicator
PLPC
PHAR
Relative Strength Index (RSI) 62.92 50.62
Support Level $206.34 $16.61
Resistance Level $223.14 $17.37
Average True Range (ATR) 8.82 0.70
MACD 0.74 -0.09
Stochastic Oscillator 99.93 38.17

Price Performance

Historical Comparison
PLPC
PHAR

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: